653
Participants
Start Date
July 22, 2019
Primary Completion Date
June 28, 2022
Study Completion Date
July 14, 2022
Follow-up
No investigational vaccine will be administered during this study
Blood sample collection
Blood sampling to assess vaccine-induced immune responses will be conducted only in cohort 1 in a subsample consisting of approximately 102 adults and 165 children (55 from each of the three paediatric age groups that were enrolled in EBOVAC-Salone: 12-17 year olds, 4-11 year olds, and 1-3 year olds).
EBOVAC Rokupr clinic, Rokupr
EBOVAC Kambia 1 clinic, Kambia
University of Sierra Leone
OTHER
Janssen Vaccines & Prevention B.V.
INDUSTRY
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Universiteit Antwerpen
OTHER
London School of Hygiene and Tropical Medicine
OTHER